Abstract
Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, loco-regional delivery, and the ability to target tumor tissue in a safe manner.
Original language | English (US) |
---|---|
Pages (from-to) | 603-616 |
Number of pages | 14 |
Journal | Surgical oncology clinics of North America |
Volume | 7 |
Issue number | 3 |
DOIs | |
State | Published - 1998 |
ASJC Scopus subject areas
- Surgery
- Oncology